ANEL MARQUEZ: Open Payments
NPI 1295498251 · WOODLAND PARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$950 in 51 payments from 19 companies in 2025. Trend: 2023 $659 · 2024 $669 · 2025 $950
Food & beverage: $736Education: $215
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $174 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Regeneron Healthcare Solutions, Inc. | 1 | $81 |
| United Therapeutics Corporation | 4 | $65 |
| Grifols USA, LLC | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Viatris Specialty LLC | 3 | $50 |
| Insmed, Inc. | 3 | $50 |
| Paratek Pharmaceuticals, Inc. | 2 | $40 |
| Philips North America LLC | 2 | $37 |
Products named: DUPIXENT, NUCALA, TRELEGY ELLIPTA, Tyvaso, Prolastin-C Liquid, FASENRA, YUPELRI, Arikayce.
Industry payments across NJ — which companies pay providers there.
